Cargando…
Coexisting myasthenia gravis, myositis, and polyneuropathy induced by ipilimumab and nivolumab in a patient with non-small-cell lung cancer: A case report and literature review
RATIONALE: Immune checkpoint inhibitors have led to the development of new approaches for cancer treatment with positive outcomes. However, checkpoint blockade is associated with a unique spectrum of immune-related adverse events (irAEs), which may cause irreversible neurological deficits and even d...
Autores principales: | Chen, Jia-Hung, Lee, Kang-Yun, Hu, Chaur-Jong, Chung, Chen-Chih |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815782/ https://www.ncbi.nlm.nih.gov/pubmed/29390370 http://dx.doi.org/10.1097/MD.0000000000009262 |
Ejemplares similares
-
Nivolumab-Induced Myasthenia Gravis Concomitant With Myocarditis, Myositis, and Hepatitis
por: Bawek, Sawyer J, et al.
Publicado: (2021) -
Prognostic factors for conversion to generalization in ocular myasthenia gravis
por: Witthayaweerasak, Juthamat, et al.
Publicado: (2021) -
Guillain-Barré syndrome associated with myasthenia gravis: Three cases report and a literature review
por: Cao, Yayun, et al.
Publicado: (2019) -
Higher Risk of Myasthenia Gravis in Patients With Thyroid and Allergic Diseases: A National Population-Based Study
por: Yeh, Jiann-Horng, et al.
Publicado: (2015) -
Low serum albumin concentrations are associated with disease severity in patients with myasthenia gravis
por: Weng, Yi-Yun, et al.
Publicado: (2016)